These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35324800)

  • 1. Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)-An Indian Perspective.
    Muthu S; Jeyaraman M; Kotner MB; Jeyaraman N; Rajendran RL; Sharma S; Khanna M; Rajendran SNS; Oh JM; Gangadaran P; Ahn BC
    Bioengineering (Basel); 2022 Mar; 9(3):. PubMed ID: 35324800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
    Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
    Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe.
    Farkas AM; Mariz S; Stoyanova-Beninska V; Celis P; Vamvakas S; Larsson K; Sepodes B
    Front Med (Lausanne); 2017; 4():53. PubMed ID: 28560211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development.
    Ancans J
    Front Immunol; 2012; 3():253. PubMed ID: 22912639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease.
    Woods N; MacLoughlin R
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32993197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014.
    Celis P; Ferry N; Hystad M; Schüßler-Lenz M; Doevendans PA; Flory E; Beuneu C; Reischl I; Salmikangas P
    Transfus Med Hemother; 2015 May; 42(3):194-9. PubMed ID: 26195933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European regulatory tools for advanced therapy medicinal products.
    Flory E; Reinhardt J
    Transfus Med Hemother; 2013 Dec; 40(6):409-12. PubMed ID: 24474890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption.
    Eder C; Wild C
    J Mark Access Health Policy; 2019; 7(1):1600939. PubMed ID: 31069029
    [No Abstract]   [Full Text] [Related]  

  • 9. ATMP Environmental Exposure Assessment in European Healthcare Settings: A Systematic Review of the Literature.
    Damerval M; Fagnoni-Legat C; Louvrier A; Fischer S; Limat S; Clairet AL; Nerich V; Madelaine I; Kroemer M
    Front Med (Lausanne); 2021; 8():713047. PubMed ID: 34926483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans.
    Labedz-Maslowska A; Szkaradek A; Mierzwinski T; Madeja Z; Zuba-Surma E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective.
    Pizevska M; Kaeda J; Fritsche E; Elazaly H; Reinke P; Amini L
    Front Med (Lausanne); 2022; 9():757647. PubMed ID: 35186986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Therapy Medicinal Products Challenges and Perspectives in Regenerative Medicine.
    Goula A; Gkioka V; Michalopoulos E; Katsimpoulas M; Noutsias M; Sarri EF; Stavropoulos C; Kostakis A
    J Clin Med Res; 2020 Dec; 12(12):780-786. PubMed ID: 33447311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Report from the Committee for Advanced Therapies (CAT). Pitfalls on the way from concept to medical treatment with advanced therapy medicinal products].
    Reiss M; Büttel IC; Schneider CK
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):822-30. PubMed ID: 21698535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects of Advanced Therapy Medicinal Products-Based Therapies in Regenerative Dentistry: Current Status, Comparison with Global Trends in Medicine, and Future Perspectives.
    Bakopoulou A
    J Endod; 2020 Sep; 46(9S):S175-S188. PubMed ID: 32950189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced therapy medicinal products: current and future perspectives.
    Hanna E; Rémuzat C; Auquier P; Toumi M
    J Mark Access Health Policy; 2016; 4():. PubMed ID: 27123193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies.
    Lederer CW; Koniali L; Buerki-Thurnherr T; Papasavva PL; La Grutta S; Licari A; Staud F; Bonifazi D; Kleanthous M
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.
    Martins JP; Santos JM; de Almeida JM; Filipe MA; de Almeida MV; Almeida SC; Água-Doce A; Varela A; Gilljam M; Stellan B; Pohl S; Dittmar K; Lindenmaier W; Alici E; Graça L; Cruz PE; Cruz HJ; Bárcia RN
    Stem Cell Res Ther; 2014 Jan; 5(1):9. PubMed ID: 24438697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging technologies for quality control of cell-based, advanced therapy medicinal products.
    Zia S; Pizzuti V; Paris F; Alviano F; Bonsi L; Zattoni A; Reschiglian P; Roda B; Marassi V
    J Pharm Biomed Anal; 2024 Aug; 246():116182. PubMed ID: 38772202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States.
    Iglesias-Lopez C; Obach M; Vallano A; Agustí A
    Cytotherapy; 2021 Mar; 23(3):261-274. PubMed ID: 33483292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advanced therapy classification procedure. Overview of experience gained so far.
    Voltz-Girolt C; Celis P; Boucaumont M; D'Apote L; Pinheiro MH; Papaluca-Amati M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):811-5. PubMed ID: 21698533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.